| P50 | author | Siamak Zohari | Q42573386 |
| | Sara Hägglund | Q56959044 |
| | Jean Francois Valarcher | Q85777720 |
| | Emmanuel Breard | Q89048303 |
| | Jenna Anderson | Q96206638 |
| | Loic Comtet | Q114776883 |
| P2093 | author name string | Guillaume Martin | |
| | Marianne Elvander | |
| | Gunilla Blomqvist | |
| | Stéphan Zientara | |
| | Mickaël Riou | |
| | Ann-Sophie Olofson | |
| | Robert Gélineau | |
| P2860 | cites work | Developing vaccines against foot-and-mouth disease and some other exotic viral diseases of livestock | Q34011420 |
| | Generation of replication-defective virus-based vaccines that confer full protection in sheep against virulent bluetongue virus challenge | Q34204054 |
| | Multiserotype protection elicited by a combinatorial prime-boost vaccination strategy against bluetongue virus | Q34238676 |
| | Evaluation of the immunogenicity of an experimental subunit vaccine that allows differentiation between infected and vaccinated animals against bluetongue virus serotype 8 in cattle | Q34347583 |
| | Protection of IFNAR (-/-) mice against bluetongue virus serotype 8, by heterologous (DNA/rMVA) and homologous (rMVA/rMVA) vaccination, expressing outer-capsid protein VP2 | Q34673436 |
| | ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells. | Q34848159 |
| | Ns1 is a key protein in the vaccine composition to protect Ifnar(-/-) mice against infection with multiple serotypes of African horse sickness virus. | Q34875697 |
| | Recombinant virus vaccine for bluetongue disease in sheep | Q36805280 |
| | Transplacental transmission of field and rescued strains of BTV-2 and BTV-8 in experimentally infected sheep | Q37359880 |
| | Did vaccination slow the spread of bluetongue in France? | Q37499381 |
| | Purification, stability, and immunogenicity analyses of five bluetongue virus proteins for use in development of a subunit vaccine that allows differentiation of infected from vaccinated animals. | Q37643307 |
| | Bluetongue control strategy, including recourse to vaccine: a critical review. | Q37839031 |
| | Control of bluetongue in Europe | Q38086685 |
| | Recombinant vaccines against bluetongue virus | Q38167166 |
| | Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection. | Q39490926 |
| | In vivo and in vitro propagation and transmission of Toggenburg orbivirus | Q39566131 |
| | Role of T-lymphocyte subsets in recovery from respiratory syncytial virus infection in calves | Q39872216 |
| | Viraemia and clinical disease in Dorset Poll sheep following vaccination with live attenuated bluetongue virus vaccines serotypes 16 and 4. | Q39931667 |
| | Experimental reproduction of severe bluetongue in sheep. | Q40090603 |
| | Bluetongue virus detection by two real-time RT-qPCRs targeting two different genomic segments. | Q40188672 |
| | Clinical disease in sheep caused by bluetongue virus serotype 8, and prevention by an inactivated vaccine | Q40301179 |
| | Comparative safety study of three inactivated BTV-8 vaccines in sheep and cattle under field conditions. | Q40390724 |
| | Vaccines against bluetongue in Europe. | Q40440398 |
| | Isolation and identification of bluetongue virus | Q40873448 |
| | The ovine cytotoxic T lymphocyte responses to bluetongue virus. | Q40910209 |
| | The non-structural proteins of bluetongue virus are a dominant source of cytotoxic T cell peptide determinants | Q41204174 |
| | Production and characterization of the neutralization antigen VP2 of bluetongue virus serotype 10 using a baculovirus expression vector | Q42074907 |
| | Immunisation with bacterial expressed VP2 and VP5 of bluetongue virus (BTV) protect α/β interferon-receptor knock-out (IFNAR(-/-)) mice from homologous lethal challenge | Q42215252 |
| | Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge | Q44320353 |
| | Bovine respiratory syncytial virus ISCOMs-Immunity, protection and safety in young conventional calves. | Q44852179 |
| | The effects of vaccination of Merino ewes with an attenuated Australian bluetongue virus serotype 23 at different stages of gestation | Q45066488 |
| | Evaluation of humoral response and protective efficacy of two inactivated vaccines against bluetongue virus after vaccination of goats | Q45105035 |
| | Evaluation of antibody-ELISA and real-time RT-PCR for the diagnosis and profiling of bluetongue virus serotype 8 during the epidemic in Belgium in 2006. | Q45398542 |
| | Design of primers and use of RT-PCR assays for typing European bluetongue virus isolates: differentiation of field and vaccine strains. | Q45400064 |
| | Recombinant capripoxviruses expressing proteins of bluetongue virus: evaluation of immune responses and protection in small ruminants | Q45401393 |
| | Antigen specificity of the ovine cytotoxic T lymphocyte response to bluetongue virus | Q45771932 |
| | Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection. | Q45782124 |
| | Live attenuated bluetongue vaccine viruses in Dorset Poll sheep, before and after passage in vector midges (Diptera: Ceratopogonidae). | Q52660116 |
| | Bluetongue in northern Europe. | Q52672039 |
| | Clinical pattern characterization of cattle naturally infected by BTV-8. | Q54310849 |
| | The length of BTV-8 viraemia in cattle according to infection doses and diagnostic techniques. | Q54387593 |
| | Field observations during the Bluetongue serotype 8 epidemic in 2006. II. Morbidity and mortality rate, case fatality and clinical recovery in sheep and cattle in the Netherlands | Q57100258 |
| P433 | issue | 49 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bluetongue virus | Q883122 |
| P304 | page(s) | 6614-6621 | |
| P577 | publication date | 2014-10-11 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Strong protection induced by an experimental DIVA subunit vaccine against bluetongue virus serotype 8 in cattle | |
| P478 | volume | 32 | |